Consulting: Life Beyond the Lab

A couple of decades ago most chemists could be assured that if they did a good job in the research organization of a profitable company they could look forward to continued employment until nor mal retirement age. Nowadays that is no longer the case. In scores of situations in recent years—involving companies as diverse as du Pont, Stauffer and Gulf—large chunks of research laboratories, or even whole labs, have been wiped out, and experienced researchers have been terminated or forc

Written byAlan Nixon
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

It's extremely difficult for scientists in their 40s and older to find places in another research organization. So more and more individuals have been forced to try their hand at something else or, if they want to stay in chemistry, to be come consultants in hopes of augmenting their diminished incomes. This is not easy even when the employers help their cast-offs get started. However, forming or joining an organization of consultants can smooth the way.

The group of which I am president was formed in 1978 through the American Chemical Society's California Section, to provide a convenient, friendly mechanism whereby retired chemists and chemical engineers would join together to carry out for-profit and non-profit ventures in consultancy. Because, for obvious reasons, we could not conduct fee-for-service operations under the aegis of the American Chemical Society, we decided to form a separate organization, which we called Calsec Consultants and incorporated ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies